IQVIA Holdings (FRA:QTS) Other Current Receivables: €1,508 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:QTS IQVIA Holdings Inc FRA:QTS
88 GF Score
Price €180.15
GF Value €217.71
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is IQVIA Holdings Other Current Receivables?

IQVIA Holdings FRA:QTS -1.04% 88 Other Current Receivables is €1,508 Mil as of Mar. 2026. GuruFocus rates FRA:QTS with a GF Score™ of 88/100 and a GF Value™ of €217.71 (Modestly Undervalued). The stock has 3 warning signs investors should review.

IQVIA Holdings's Other Current Receivables for the quarter that ended in Mar. 2026 was €1,508 Mil.

IQVIA Holdings's quarterly Other Current Receivables declined from Sep. 2025 (€1,611.13 Mil) to Dec. 2025 (€1,502.19 Mil) but then increased from Dec. 2025 (€1,502.19 Mil) to Mar. 2026 (€1,507.70 Mil).

IQVIA Holdings's annual Other Current Receivables declined from Dec. 2023 (€1,778.98 Mil) to Dec. 2024 (€1,766.75 Mil) and declined from Dec. 2024 (€1,766.75 Mil) to Dec. 2025 (€1,502.19 Mil).

IQVIA Holdings Other Current Receivables Related Terms

IQVIA Holdings Other Current Receivables Historical Data

* Premium members only.

The historical data trend for IQVIA Holdings's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IQVIA Holdings Other Current Receivables Chart

IQVIA Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,180.59 1,539.66 1,778.98 1,766.75 1,502.19

IQVIA Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,759.35 1,665.51 1,611.13 1,502.19 1,507.70
FRA:QTS
88GF Score
IQVIA Holdings Inc FRA:QTS
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IQVIA Holdings Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of €1,508 Mil mean?
IQVIA Holdings (FRA:QTS) has a Other Current Receivables of €1,508 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on IQVIA Holdings and its competitors.
Is IQVIA Holdings' Other Current Receivables too high?
IQVIA Holdings' current Other Current Receivables is €1,508 Mil. Overall, IQVIA Holdings has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IQVIA Holdings' Other Current Receivables compare to WAT and ILMN?
IQVIA Holdings' Other Current Receivables of €1,508 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Medical Diagnostics & Research company?
A good Other Current Receivables depends on the Medical Diagnostics & Research industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on IQVIA Holdings and its competitors. IQVIA Holdings's current Other Current Receivables is €1,508 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IQVIA Holdings stock overvalued right now?
Based on GuruFocus' analysis, IQVIA Holdings (FRA:QTS) is currently considered Modestly Undervalued. The stock's GF Value™ is €217.71, compared to a current price of €180.15 — trading 17.3% below its estimated fair value. The current Other Current Receivables is €1,508 Mil. IQVIA Holdings' overall GF Score™ is 88/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For IQVIA Holdings (FRA:QTS), the current Other Current Receivables is €1,508 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IQVIA Holdings (FRA:QTS) Overvalued in 2026?

Based on GuruFocus' analysis, IQVIA Holdings stock appears to be undervalued. The current stock price of €180.15 is trading 17.3% below its estimated GF Value™ of €217.71. GuruFocus considers IQVIA Holdings to be Modestly Undervalued.

Key valuation signals for FRA:QTS:

  • Other Current Receivables: €1,508 Mil
  • GF Value™: €217.71 vs. price of €180.15 (17.3% below fair value)
  • GF Score™: 88/100 with 3 warning signs

No single metric tells the full story. See the FRA:QTS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IQVIA Holdings Business Description

Address 2400 Ellis Road, Durham, NC, USA, 27703
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
88GF Score

Get the complete analysis for FRA:QTS

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€180.15
Price
€217.71
GF Value